Unternehmen wird geladen
Keep exploring
The themes Alcon is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Medical Instruments and Supplies
Graded A or B and worth $2B or more: A first, then the largest.
ISRGIntuitive Surgical, Inc.152,5B $A+
MDLNMedline Inc.52,6B $A
BLCOBausch & Lomb Corp7,6B $A-
ATRCAtriCure, Inc.2,9B $A
RMDResMed Inc.33,6B $B+
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21. Okt. 2026CBGraded C, now B
MCKMckesson Corporation4. Nov. 2026BAGraded B, now A
CVSCVS Health Corp4. Nov. 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4. Nov. 2026BAGraded B, now A
BIIBBiogen Inc.28. Okt. 2026BAGraded B, now A
Womit das Unternehmen Geld verdient
- Surgical products and services56 %
- Vision-care products45 %
Die Umsatzanteile sind Schätzungen für FY2025 und keine Zahlen aus einem eingereichten Bericht.
Konkurriert mit
Was es verkauft6
UNITY VCS and UNITY CS
Equipment systems used for retinal and cataract surgery. They help surgeons remove eye tissue or a cloudy natural lens and replace it.
PanOptix Pro
An artificial lens implanted during cataract surgery, designed to help patients see at near, middle and far distances.
Hydrus Microstent
A small device implanted during cataract surgery to help fluid drain from the eye and lower pressure in some people with glaucoma.
3 weitere anzeigen
DAILIES TOTAL1
A daily disposable contact lens designed with a high-water-content surface for comfort.
Systane
Eye drops that temporarily relieve burning and irritation associated with dry eye.
TRYPTYR
Prescription eye drops for dry eye disease that stimulate natural tear production.
Wer es kauft5
- Hospitals and ambulatory surgery centers buy surgical equipment, implanted lenses and procedure supplies.
- Eye surgeons select and use Alcon’s surgical products and equipment in procedures.
- Optometrists and ophthalmologists recommend or sell contact lenses and eye-health products to patients.
2 weitere anzeigen
- Optical chains, retailers and pharmacies sell contact lenses and eye-health products to consumers.
- Distributors sell and deliver products in markets where Alcon does not have local operations.
Worauf es steht, und was es umwerfen könnte
Wovon das Geschäft abhängt
- 1Sales of contact lenses and eye-health products are influenced by recommendations from eye-care professionals, consumer preferences and retailer access.
- 2Some components used in surgical, dry-eye and pharmaceutical products are available from only one or a limited number of health-authority-approved suppliers.
- 3Sales of prescription products and products used in surgery depend in part on regulatory approval and health-insurance or government reimbursement rules.
Was schiefgehen könnte
- 1Regulatory approvals, manufacturing requirements and ongoing product-safety rules can delay launches or lead to production interruptions, recalls or restrictions on sales.
- 2Disruption at important facilities or shortages of components from single or limited suppliers could interrupt production and delay customer deliveries.
- 3Competition, reimbursement changes and price controls could make it harder to sell products at current prices; Alcon also depends on developing and launching products that meet medical and customer needs.
Über Alcon Inc.
Alcon makes equipment and disposable supplies used in cataract, retinal, laser-vision and glaucoma surgery, as well as artificial lenses implanted during cataract operations. It also sells daily and reusable contact lenses and eye drops for dry eye, allergies, glaucoma and contact-lens care. Hospitals and surgery centers buy surgical products, while eye-care practices, retailers, pharmacies and distributors sell or prescribe its vision-care products.
- Hauptsitz
- Geneva, Switzerland
- Gegründet
- 1945
- Beschäftigte
- 25,000+ (Q2 2026, high)
- Notiert an
- NYSE
- Geschäftsjahresende
- December 31
Gebaut aus den eigenen Einreichungen von Alcon Inc. bei der US-Börsenaufsicht Securities and Exchange Commission (SEC). Die Zahlen sind wie berichtet, die Historie je Aktie auf die heutige Aktienbasis umgerechnet. Dies beschreibt ein Unternehmen — es ist keine Anlageberatung und keine Kauf- oder Verkaufsempfehlung.
